Kwangsik Park
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kwangsik Park has a total of 90 co-authors. Here are the top co-authors by number of shared publications:
Handule Lee
College of Pharmacy, Dongduk Women's University, Seoul 02748, Korea
18 shared publicationsJuyoung Park
College of Pharmacy, Dongduk Women's University, 60, Hwarang-ro, 13-gil, Seongbuk-gu, Seoul, 02748 Republic of Korea
13 shared publicationsEun-Jung Park
College of Pharmacy, Dongduk Women's University, Seoul, Korea
7 shared publicationsJonghye Choi
College of Pharmacy, Dongduk Women's University, 60, Hwarang-ro, 13-gil Seongbuk-gu, Seoul, 02748, Korea
6 shared publicationsKyunghee Choi
National Institute of Health, Incheon, 404-708, Korea
5 shared publicationsNgoc Minh-Hong Hoang
College of Pharmacy, Dongduk Women's University, Seoul 02748, Korea
5 shared publications
Latest Publications
- 2 August 2026
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 515, 117978
Integrated approaches to testing and assessment (IATA) for the estrogenic response of 14 commonly used chemicals in consumer products
- 2 August 2026
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 515, 117978
Integrated approaches to testing and assessment (IATA) for the estrogenic response of 14 commonly used chemicals in consumer products
- Open Access
- 29 November 2025
- Published by Elsevier in Toxicology Letters
- Vol. 414, 111784
Comprehensive estrogenicity assessment of 4-methylbenzophenone via in vivo, in vitro, and in silico approaches within an integrated testing strategy framework
- 29 November 2025
- Published by Elsevier in Toxicology Letters
- Vol. 414, 111784
Open AccessComprehensive estrogenicity assessment of 4-methylbenzophenone via in vivo, in vitro, and in silico approaches within an integrated testing strategy framework
- 25 November 2025
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 208, 115867
Integrated approaches to testing and assessment for the endocrine disrupting activity of tartrazine based on adverse outcome pathways and OECD frameworks
- 25 November 2025
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 208, 115867
Integrated approaches to testing and assessment for the endocrine disrupting activity of tartrazine based on adverse outcome pathways and OECD frameworks
- Open Access
- 4 November 2025
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 506, 117628
Integrated in silico and in vitro assessment of estrogen and androgen receptor activity of 10 selected PFAS within an Integrated Approach to Testing and Assessment (IATA)
- 4 November 2025
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 506, 117628
Open AccessIntegrated in silico and in vitro assessment of estrogen and androgen receptor activity of 10 selected PFAS within an Integrated Approach to Testing and Assessment (IATA)
- 9 July 2025
- Published by Springer Nature in Toxicological Research
- Vol. 41 (6) , 601-610
Case study on the evaluation of skin sensitization for 23 selected fragrance ingredients using a defined approach based on OECD Guideline 497
Twenty-three single-ingredient substances, selected from materials labeled as allergens in cosmetic fragrances, were assessed for skin sensitization potential using a defined approach (DA) based on the OECD Guideline 497 Integrated Testing Strategy version 2 (ITSv2). According to the ITSv2, skin hypersensitivity data for these selected substances were integrated. In chemico data (from the Direct Peptide Reactivity Assay, DPRA) and in vitro data (from the human Cell Line Activation Test, h-CLAT) were obtained from existing databases, while in silico data were generated via the automated workflow of the OECD QSAR Toolbox. The DA for skin sensitization, which combines QSAR predictions with DPRA and h-CLAT test results, categorized 17 substances, including 2-benzylideneheptanal, as “Sensitizers”; 5 substances, including 4-methoxybenzyl alcohol, as “Inconclusive”; and citronellol alone was categorized as “Not Classified.” The outcomes from the Local Lymph Node Assay (LLNA) for substances identified as skin sensitizers by the DA method demonstrated similar classification patterns to those from DA. These results underscore the necessity of integrating comprehensive in vitro, in chemico, and in silico data for accurate evaluation of potential skin sensitizers. This case study could aid in enhancing the safety assessments of potential skin sensitizers using DA; however, final categorization is subject to validation by regulatory authorities.
- 9 July 2025
- Published by Springer Nature in Toxicological Research
- Vol. 41 (6) , 601-610
Case study on the evaluation of skin sensitization for 23 selected fragrance ingredients using a defined approach based on OECD Guideline 497
Twenty-three single-ingredient substances, selected from materials labeled as allergens in cosmetic fragrances, were assessed for skin sensitization potential using a defined approach (DA) based on the OECD Guideline 497 Integrated Testing Strategy version 2 (ITSv2). According to the ITSv2, skin hypersensitivity data for these selected substances were integrated. In chemico data (from the Direct Peptide Reactivity Assay, DPRA) and in vitro data (from the human Cell Line Activation Test, h-CLAT) were obtained from existing databases, while in silico data were generated via the automated workflow of the OECD QSAR Toolbox. The DA for skin sensitization, which combines QSAR predictions with DPRA and h-CLAT test results, categorized 17 substances, including 2-benzylideneheptanal, as “Sensitizers”; 5 substances, including 4-methoxybenzyl alcohol, as “Inconclusive”; and citronellol alone was categorized as “Not Classified.” The outcomes from the Local Lymph Node Assay (LLNA) for substances identified as skin sensitizers by the DA method demonstrated similar classification patterns to those from DA. These results underscore the necessity of integrating comprehensive in vitro, in chemico, and in silico data for accurate evaluation of potential skin sensitizers. This case study could aid in enhancing the safety assessments of potential skin sensitizers using DA; however, final categorization is subject to validation by regulatory authorities.
- 6 May 2025
- Published by Springer Nature in Toxicological Research
- Vol. 41 (4) , 407-415
Repeated dose toxicity of 4-methylbenzophenone: hepatotoxic and nephrotoxic effects in female Sprague–Dawley rats
4-Methylbenzophenone (4-MBP), a derivative of benzophenone commonly utilized in consumer products, has elicited significant safety concerns due to its potential to migrate from food packaging materials and its structural similarity to known toxicants. This investigation sought to elucidate the toxicological profile of 4-MBP in female Sprague-Dawley rats following a 7-day repeated oral exposure to doses of 100, 200, and 400 mg/kg. The results demonstrated pronounced toxicity, as evidenced by high mortality, decreased body weight, clinical signs of weakness, and increased relative liver weights. Biochemical analysis revealed significant elevations in liver enzymes (AST, ALT, and GGT), lipid dysregulation, and increased glucose levels, which are indicative of hepatic dysfunction. Histopathological examination confirmed hepatocyte hypertrophy and mild renal tubular vacuolation, suggesting hepatotoxicity and nephrotoxicity, respectively. Hematological findings further revealed a decrease in white blood cell counts and alterations in immune cell populations, indicating a compromised immune function. Notably, no significant pulmonary lesions were observed, suggesting organ-specific toxicity. This study provides critical insights into the toxic effects of 4-MBP, identifies hepatotoxic and nephrotoxic risks, and highlights the need for further investigation in the field of regulatory toxicology. The present findings are crucial for determining safe exposure limits and contributing to the regulatory assessment of 4-MBP safety and public health risks.
- 6 May 2025
- Published by Springer Nature in Toxicological Research
- Vol. 41 (4) , 407-415
Repeated dose toxicity of 4-methylbenzophenone: hepatotoxic and nephrotoxic effects in female Sprague–Dawley rats
4-Methylbenzophenone (4-MBP), a derivative of benzophenone commonly utilized in consumer products, has elicited significant safety concerns due to its potential to migrate from food packaging materials and its structural similarity to known toxicants. This investigation sought to elucidate the toxicological profile of 4-MBP in female Sprague-Dawley rats following a 7-day repeated oral exposure to doses of 100, 200, and 400 mg/kg. The results demonstrated pronounced toxicity, as evidenced by high mortality, decreased body weight, clinical signs of weakness, and increased relative liver weights. Biochemical analysis revealed significant elevations in liver enzymes (AST, ALT, and GGT), lipid dysregulation, and increased glucose levels, which are indicative of hepatic dysfunction. Histopathological examination confirmed hepatocyte hypertrophy and mild renal tubular vacuolation, suggesting hepatotoxicity and nephrotoxicity, respectively. Hematological findings further revealed a decrease in white blood cell counts and alterations in immune cell populations, indicating a compromised immune function. Notably, no significant pulmonary lesions were observed, suggesting organ-specific toxicity. This study provides critical insights into the toxic effects of 4-MBP, identifies hepatotoxic and nephrotoxic risks, and highlights the need for further investigation in the field of regulatory toxicology. The present findings are crucial for determining safe exposure limits and contributing to the regulatory assessment of 4-MBP safety and public health risks.
- Open Access
- 12 April 2025
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 499, 117344
Estrogenic and androgenic activity of tert-butyl phenolic antioxidants assessed by in vitro receptor transcriptional activation and their association with in silico molecular docking analysis
- 12 April 2025
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 499, 117344
Open AccessEstrogenic and androgenic activity of tert-butyl phenolic antioxidants assessed by in vitro receptor transcriptional activation and their association with in silico molecular docking analysis
- Open Access
- 4 April 2025
- Published by The Korean Society of Environmental Health and Toxicology in Environmental Analysis Health and Toxicology
- Vol. 40 (Special ) , e2025s03
Systematic review and Integrated Approaches to Testing and Assessment (IATA) of PFOA and PFOS for endocrine disrupting effects based on the AOP framework
Perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) have been extensively used as surfactants, surface protectors, food packaging materials, and fire-retardants. Due to serious adverse effects on human and environment, they are now considered as legacy compounds. In this study, the effects of PFOA and PFOS on endocrine disruption were assessed using the Integrated Approaches to Testing and Assessment (IATA) methodology based on the adverse outcome pathway (AOP). PFOA/PFOS in vitro data for enzyme activities for steroidogenesis, hormone levels of 17β-estradiol and testosterone, receptor binding capacity, receptor transcriptional activation, cell proliferation and differentiation were collated and assessed to elucidate the association between the data with the human adverse outcomes. Multiple studies indicate that PFOA/PFOS alter enzyme activities, hormone levels, receptor transcription, and cell proliferation. Moreover, associations were found between in vitro data and human outcomes including semen quality, menarche, menopause, menstrual cycle, infertility, miscarriage, cancer, and birth weight. This study effectively links toxic mechanisms to human adverse outcomes of PFOA and PFOS. However, in vitro data based on the molecular initial events (MIEs) and key events (KEs) in AOP frame works are not enough and often inconsistent for integrated assessment, which suggest that more data for endocrine disruption are required for clear and complete IATA of PFOA and PFOS.
- 4 April 2025
- Published by The Korean Society of Environmental Health and Toxicology in Environmental Analysis Health and Toxicology
- Vol. 40 (Special ) , e2025s03
Open AccessSystematic review and Integrated Approaches to Testing and Assessment (IATA) of PFOA and PFOS for endocrine disrupting effects based on the AOP framework
Perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) have been extensively used as surfactants, surface protectors, food packaging materials, and fire-retardants. Due to serious adverse effects on human and environment, they are now considered as legacy compounds. In this study, the effects of PFOA and PFOS on endocrine disruption were assessed using the Integrated Approaches to Testing and Assessment (IATA) methodology based on the adverse outcome pathway (AOP). PFOA/PFOS in vitro data for enzyme activities for steroidogenesis, hormone levels of 17β-estradiol and testosterone, receptor binding capacity, receptor transcriptional activation, cell proliferation and differentiation were collated and assessed to elucidate the association between the data with the human adverse outcomes. Multiple studies indicate that PFOA/PFOS alter enzyme activities, hormone levels, receptor transcription, and cell proliferation. Moreover, associations were found between in vitro data and human outcomes including semen quality, menarche, menopause, menstrual cycle, infertility, miscarriage, cancer, and birth weight. This study effectively links toxic mechanisms to human adverse outcomes of PFOA and PFOS. However, in vitro data based on the molecular initial events (MIEs) and key events (KEs) in AOP frame works are not enough and often inconsistent for integrated assessment, which suggest that more data for endocrine disruption are required for clear and complete IATA of PFOA and PFOS.
- Open Access
Applications of Tert-Butyl-Phenolic Antioxidants in Consumer Products and Their Potential Toxicities in Humans
Tert-butyl phenolic antioxidants (TBP-AOs) are employed to inhibit oxidation and function as stabilizers and protectants in a broad spectrum of consumer products, such as food packaging, adhesives, lubricants, plastics, and cosmetics. The extensive utilization of TBP-AOs results in human exposure through various pathways. Furthermore, some TBP-AOs have been identified as potential endocrine disruptors and may cause liver and lung damage, as well as allergic reactions. Considering their varied applications and potential toxicity, a detailed evaluation of their safety profiles is imperative. However, existing research is often segmented and tends to focus narrowly on specific compounds. Consequently, this review collates recent data on TBP-AOs regarding their production, exposure, and toxicity, incorporating different databases and prior studies, as well as predictions of toxicity using ADMET. Our review strives to offer a comprehensive overview of the characteristics and health effects of TBP-AOs to guide future research and inform policy decisions.
Open AccessApplications of Tert-Butyl-Phenolic Antioxidants in Consumer Products and Their Potential Toxicities in Humans
Tert-butyl phenolic antioxidants (TBP-AOs) are employed to inhibit oxidation and function as stabilizers and protectants in a broad spectrum of consumer products, such as food packaging, adhesives, lubricants, plastics, and cosmetics. The extensive utilization of TBP-AOs results in human exposure through various pathways. Furthermore, some TBP-AOs have been identified as potential endocrine disruptors and may cause liver and lung damage, as well as allergic reactions. Considering their varied applications and potential toxicity, a detailed evaluation of their safety profiles is imperative. However, existing research is often segmented and tends to focus narrowly on specific compounds. Consequently, this review collates recent data on TBP-AOs regarding their production, exposure, and toxicity, incorporating different databases and prior studies, as well as predictions of toxicity using ADMET. Our review strives to offer a comprehensive overview of the characteristics and health effects of TBP-AOs to guide future research and inform policy decisions.